Beit Jala Pharmaceutical Company (PEX:BJP)
Palestine
· Delayed Price · Currency is JOD 3.620
+0.020 (0.56%)
At close: Jan 13, 2026
PEX:BJP Ratios and Metrics
Market cap in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 25 | 25 | 20 | 20 | 20 | 19 | Upgrade
|
| Market Cap Growth | - | 28.57% | - | -1.75% | 5.56% | 5.88% | Upgrade
|
| Enterprise Value | 24 | 23 | 20 | 19 | 21 | 21 | Upgrade
|
| Last Close Price | 3.62 | 3.60 | 2.68 | 2.58 | 2.54 | 2.40 | Upgrade
|
| PE Ratio | 9.27 | 9.22 | 11.16 | 10.67 | 10.07 | 21.70 | Upgrade
|
| PS Ratio | 1.98 | 1.97 | 2.03 | 2.04 | 1.85 | 1.94 | Upgrade
|
| PB Ratio | 1.29 | 1.28 | 1.27 | 1.34 | 1.51 | 1.52 | Upgrade
|
| P/TBV Ratio | 1.29 | 1.28 | 1.27 | 1.34 | 1.51 | 1.52 | Upgrade
|
| P/FCF Ratio | 173.99 | 173.03 | 89.61 | 29.24 | 7.09 | 70.56 | Upgrade
|
| P/OCF Ratio | 5.67 | 5.64 | 21.66 | 10.13 | 6.20 | 17.36 | Upgrade
|
| EV/Sales Ratio | 1.84 | 1.83 | 2.10 | 2.00 | 1.91 | 2.16 | Upgrade
|
| EV/EBITDA Ratio | 3.74 | 3.72 | 7.78 | 5.89 | 6.22 | 9.94 | Upgrade
|
| EV/EBIT Ratio | 7.09 | 7.05 | 10.53 | 8.90 | 8.73 | 19.01 | Upgrade
|
| EV/FCF Ratio | 161.64 | 160.68 | 92.58 | 28.65 | 7.30 | 78.56 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.09 | 0.06 | 0.14 | 0.27 | Upgrade
|
| Debt / EBITDA Ratio | 0.10 | 0.10 | 0.56 | 0.29 | 0.55 | 1.57 | Upgrade
|
| Debt / FCF Ratio | 4.24 | 4.24 | 6.64 | 1.39 | 0.65 | 12.41 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.04 | 0.06 | 0.02 | 0.06 | 0.20 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.12 | -0.12 | 0.35 | 0.07 | 0.23 | 1.17 | Upgrade
|
| Net Debt / FCF Ratio | -5.35 | -5.35 | 4.12 | 0.35 | 0.26 | 9.23 | Upgrade
|
| Asset Turnover | 0.58 | 0.58 | 0.51 | 0.52 | 0.56 | 0.53 | Upgrade
|
| Inventory Turnover | 2.08 | 2.08 | 1.94 | 2.02 | 2.26 | 2.64 | Upgrade
|
| Quick Ratio | 3.59 | 3.59 | 2.07 | 2.49 | 1.60 | 1.18 | Upgrade
|
| Current Ratio | 5.56 | 5.56 | 3.52 | 4.45 | 2.44 | 1.94 | Upgrade
|
| Return on Equity (ROE) | 15.57% | 15.57% | 11.70% | 13.23% | 15.45% | 7.13% | Upgrade
|
| Return on Assets (ROA) | 9.49% | 9.49% | 6.30% | 7.22% | 7.60% | 3.77% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.08% | 17.18% | 11.59% | 14.06% | 13.67% | 6.32% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.50% | 15.50% | 11.40% | 13.30% | 15.70% | 7.60% | Upgrade
|
| Earnings Yield | 10.79% | 10.85% | 8.96% | 9.37% | 9.93% | 4.61% | Upgrade
|
| FCF Yield | 0.57% | 0.58% | 1.12% | 3.42% | 14.11% | 1.42% | Upgrade
|
| Dividend Yield | 3.31% | - | 4.48% | 3.87% | 3.94% | 4.16% | Upgrade
|
| Payout Ratio | 30.72% | 30.72% | 39.86% | 38.10% | 35.33% | 80.36% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | 0.01% | - | - | - | - | Upgrade
|
| Total Shareholder Return | 3.32% | 0.01% | 4.48% | 3.87% | 3.94% | 4.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.